V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330006622 | 330003368 | null | 68.1 | Radical (R) | 2013-03-20 | 2013-06-11 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | 02 | N | 330002900 | NOT MATCHED |
| 330006623 | 330003371 | null | 11.6 | Disease modification (D) | 2016-04-24 | 2016-10-10 | NB BEACON Temozolomide Irinotecan | 1 | N | 330002931 | NOT MATCHED |
| 330006624 | 330010245 | null | null | Curative (C) | 2017-11-05 | 2017-11-08 | Cisplatin + Radiotherapy | null | N | 330002933 | CISPLATIN + RT |
| 330006625 | 330003372 | 0 | 60.2 | Curative (C) | 2018-04-09 | 2018-04-09 | CISPLATIN + RT | N | N | 330002942 | CISPLATIN + RT |
| 330006626 | 330003373 | 1.8 | 10.1 | Curative (C) | 2018-01-18 | 2018-01-19 | NB HRNBL-1 TVD | 02 | N | 330002942 | NOT MATCHED |
| 330006627 | 330003375 | 1.83 | 96.6 | Curative (C) | 2013-11-06 | 2013-12-20 | CISPLATIN + RT | N | Y | 330002949 | CISPLATIN + RT |
| 330006628 | 330003376 | 1.67 | 86 | Not known (9) | 2013-07-11 | 2013-07-12 | Cisplatin + Radiotherapy + CISPLATIN | 2 | Y | 330002955 | CISPLATIN + RT |
| 330006629 | 330003377 | null | 22.1 | Curative (C) | 2014-07-30 | 2014-08-07 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | null | Y | 330002960 | NOT MATCHED |
| 330006630 | 330003378 | 1.76 | null | Palliative (P) | 2015-01-29 | 2015-02-16 | CISPLATIN + RT | N | Y | 330002961 | CISPLATIN + RT |
| 330006631 | 330003378 | 1.73 | 96.8 | Not known (9) | 2014-08-23 | 2014-09-20 | Cisplatin 100 + RT(H&N) 1 day | N | N | 330002961 | CISPLATIN + RT |
| 330006634 | 330003380 | 0 | 14 | Neo-adjuvant (N) | null | 2014-03-22 | NB HRNBL-1 COJEC Ind COURSE C | Y | N | 330002979 | NOT MATCHED |
| 330006635 | 330003381 | 0 | 11.5 | Disease modification (D) | 2016-11-01 | 2016-11-01 | NB HRNBL-1 COJEC Ind COURSE A | 02 | N | 330002981 | NOT MATCHED |
| 330006636 | 330003385 | 1.15 | 16.45 | Curative (C) | 2018-05-09 | 2018-05-09 | NB Low/Intermed risk guidelines CADO | Y | N | 330002986 | NOT MATCHED |
| 330006637 | 330003386 | null | 13 | Disease modification (D) | 2015-09-15 | 2016-02-29 | NB BEACON Temozolomide Irinotecan | N | N | 330002986 | NOT MATCHED |
| 330006638 | 330003387 | 1.14 | null | Curative (C) | 2014-06-03 | 2014-06-04 | NB HRNBL-1 TVD | 2 | N | 330002991 | NOT MATCHED |
| 330006639 | 330003389 | null | 73.7 | Adjuvant (A) | 2015-02-28 | 2015-03-02 | Cisplatin 100 + RT(H&N) 1 day | 2 | Y | 330002999 | CISPLATIN + RT |
| 330006640 | 330003390 | null | 60.2 | Palliative (P) | 2015-02-24 | 2015-03-01 | NB Low/Intermed risk guidelines CADO | 02 | N | 330003007 | NOT MATCHED |
| 330006641 | 330003391 | null | 36.9 | Curative (C) | null | 2017-09-20 | NB HRNBL-1 TVD | null | null | 330003010 | NOT MATCHED |
| 330006642 | 330003392 | 0 | 19.5 | null | null | 2013-11-25 | NB HRNBL-1 COJEC Ind COURSE C | null | null | 330003012 | NOT MATCHED |
| 330006643 | 330007806 | null | 62.3 | Curative (C) | 2016-09-30 | 2016-10-16 | Cisplatin 100 + RT(H&N) 1 day | N | null | 330003012 | CISPLATIN + RT |
| 330006644 | 330003393 | null | 16.3 | Adjuvant (A) | 2015-12-20 | 2015-12-20 | NB HRNBL-1 Isotretinoin | N | N | 330003016 | NOT MATCHED |
| 330006645 | 330003395 | 0 | 56.7 | Curative (C) | 2017-07-07 | 2017-07-13 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330003017 | NOT MATCHED |
| 330006646 | 330003397 | 0.85 | 90.7 | null | 2016-03-22 | 2016-04-28 | NB HRNBL-1 Isotretinoin | 02 | N | 330003019 | NOT MATCHED |
| 330006647 | 330007807 | 0 | 21.3 | Adjuvant (A) | 2017-04-02 | 2017-05-17 | NB BEACON Temozolomide Irinotecan | 01 | N | 330003028 | NOT MATCHED |
| 330006648 | 330003401 | 1.13 | 19 | Adjuvant (A) | 2015-06-13 | 2015-06-13 | LCHIV SL-IT | 1 | N | 330003028 | NOT MATCHED |
| 330006649 | 330003402 | 1.7 | 97.2 | Curative (C) | null | 2014-07-30 | Cisplatin 100 + RT(H&N) 1 day | null | null | 330003042 | CISPLATIN + RT |
| 330006650 | 330010251 | 0.8 | 17.3 | Palliative (P) | 2015-12-25 | 2015-12-25 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + FILGRASTIM + METHOTREXATE | 02 | null | 330003049 | NOT MATCHED |
| 330006651 | 330003404 | 1.71 | null | Curative (C) | 2016-06-19 | 2016-07-04 | CISPLATIN + RT | N | N | 330003051 | CISPLATIN + RT |
| 330006652 | 330003404 | 1.86 | 8 | Disease modification (D) | 2014-09-25 | 2014-10-22 | CNS GCT II Non Germin - Std PEI | 02 | N | 330003051 | NOT MATCHED |
| 330006653 | 330003406 | 0 | 16.4 | Curative (C) | 2017-12-08 | 2017-12-09 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | 1 | N | 330003069 | NOT MATCHED |
| 330006654 | 330003407 | 0.92 | 26.9 | Curative (C) | 2014-03-27 | 2015-01-26 | NB HRNBL-1 COJEC Ind COURSE B | null | null | 330003076 | NOT MATCHED |
| 330006655 | 330003407 | null | 22.7 | Curative (C) | 2014-07-01 | 2014-12-10 | NB 13 cis-RA (Isotretinoin) | 02 | null | 330003076 | NOT MATCHED |
| 330006656 | 330003410 | 1.93 | 72 | Adjuvant (A) | 2013-10-26 | 2013-11-06 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330003086 | CISPLATIN + RT |
| 330006657 | 330003410 | 1.71 | 73.2 | Curative (C) | 2014-07-08 | 2014-07-08 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | 330003086 | CISPLATIN + RT |
| 330006658 | 330012336 | 0 | 87.6 | Curative (C) | 2014-12-01 | 2015-09-13 | Olaratumab | null | N | 330003127 | NOT MATCHED |
| 330006659 | 330003411 | 1.73 | 129.3 | Curative (C) | 2017-01-19 | 2017-01-19 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330003127 | CISPLATIN + RT |
| 330006660 | 330003412 | 1.66 | 12.3 | Adjuvant (A) | 2016-08-12 | 2017-02-11 | NB Low/Intermed risk guidelines CADO | 2 | null | 330003144 | NOT MATCHED |
| 330006661 | 330003413 | 0 | 9.8 | Curative (C) | 2013-06-14 | 2013-06-16 | NB Low/Intermed risk guidelines CADO | Y | N | 330003157 | NOT MATCHED |
| 330006662 | 330003415 | 1.64 | 78 | Curative (C) | 2014-09-05 | 2014-09-05 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 330003160 | CISPLATIN + RT |
| 330006663 | 330003416 | null | 14.8 | Adjuvant (A) | 2016-01-14 | 2016-04-25 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330003163 | NOT MATCHED |
| 330006664 | 330003416 | null | 47 | Curative (C) | null | 2015-01-18 | Cisplatin + Radiotherapy | null | null | 330003163 | CISPLATIN + RT |
| 330006665 | 330003416 | 1.15 | 57.1 | Disease modification (D) | 2016-02-12 | 2016-02-19 | EW Rel rEECur Topotecan/Cyclophosphamide | 01 | N | 330003163 | NOT MATCHED |
| 330006666 | 330003417 | 1.78 | null | Curative (C) | null | 2016-07-06 | Cisplatin 100 + RT(H&N) 1 day | null | null | 330003174 | CISPLATIN + RT |
| 330006667 | 330003418 | 0 | 22.7 | Adjuvant (A) | 2018-02-07 | 2018-02-28 | NB HRNBL-1 BUMEL MAT | null | null | 330003181 | NOT MATCHED |
| 330006668 | 330007820 | 1.65 | 130.6 | Curative (C) | 2016-10-03 | 2016-10-03 | Cisplatin + Radiotherapy | N | null | 330003184 | CISPLATIN + RT |
| 330006669 | 330007820 | null | 12 | Adjuvant (A) | 2014-09-11 | 2014-10-13 | NB HRNBL-1 BUMEL MAT | N | null | 330003184 | NOT MATCHED |
| 330006670 | 330003422 | 0 | 35.1 | Curative (C) | 2013-09-03 | 2014-01-02 | CNS LGG Temozolomide | null | null | 330003202 | NOT MATCHED |
| 330006671 | 330003423 | 0 | 47.5 | Palliative (P) | 2014-03-25 | 2014-04-14 | NB HRNBL-1 COJEC Ind COURSE C | 02 | Y | 330003202 | NOT MATCHED |
| 330006672 | 330003424 | 0 | 25.8 | Adjuvant (A) | 2016-09-02 | 2016-10-01 | NB HRNBL-1 COJEC Ind COURSE C | N | N | 330003214 | NOT MATCHED |
| 330006673 | 330003426 | 0.91 | 0 | Palliative (P) | 2015-09-06 | 2015-09-11 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | N | N | 330003220 | NOT MATCHED |